Literature DB >> 2446670

Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism.

C Joborn1, J Hetta, J Rastad, H Agren, G Akerström, S Ljunghall.   

Abstract

This prospective study included 32 patients with primary hyperparathyroidism (HPT). As compared with a healthy reference group, the patients had pronounced psychiatric symptomatology [CPRS score 17.2 +/- 9.0 (SD) versus 4.4 +/- 2.0], which was mainly affective in character. The severity of symptoms was not related to the serum calcium or parathyroid hormone concentrations. The majority of the patients had low CSF concentrations of monoamine metabolites (5-HIAA, HVA, and MHPG) and, in particular, those with the most severe psychiatric symptoms had low values for 5-HIAA. At follow-up, 1 year after parathyroid surgery, the patients displayed a clear improvement in mental health (CPRS score 4.4 +/- 3.0) together with an increase in CSF concentrations of 5-HIAA and HVA. The study demonstrates that significant psychiatric disturbances, which can be improved/normalized by surgery, are common in patients with HPT and are possibly related to changes in the central nervous system turnover of monoamines.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2446670     DOI: 10.1016/0006-3223(88)90085-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Regional cerebral blood flow abnormalities in patients with primary hyperparathyroidism.

Authors:  Tevfik Fikret Cermik; Meryem Kaya; Betül Uğur-Altun; Deniz Bedel; Sakir Berkarda; Omer N Yiğitbaşi
Journal:  Neuroradiology       Date:  2007-01-05       Impact factor: 2.804

2.  Psychiatric morbidity in primary hyperparathyroidism.

Authors:  C Joborn; J Hetta; H Johansson; J Rastad; H Agren; G Akerström; S Ljunghall
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 3.  Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease.

Authors:  E L Kaplan; T Yashiro; G Salti
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

4.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 5.  The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism.

Authors:  L Grimelius; G Akerström; L Bondeson; C Juhlin; H Johansson; S Ljunghall; J Rastad
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 6.  Asymptomatic primary hyperparathyroidism.

Authors:  B J Harrison; M H Wheeler
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

7.  Surgical treatment of primary hyperparathyroidism: an institutional perspective.

Authors:  J A van Heerden; C S Grant
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

8.  Surgery for sporadic primary hyperparathyroidism in the elderly.

Authors:  U Ohrvall; G Akerström; S Ljunghall; E Lundgren; C Juhlin; J Rastad
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

9.  Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism.

Authors:  Nancy D Perrier; Laura H Coker; Kashemi D Rorie; Nicole S Burbank; Kimberly A Kirkland; Leah V Passmore; Terry Tembreull; David A Stump; Paul J Laurienti
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

10.  Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study.

Authors:  A K Chan; Q Y Duh; M H Katz; A E Siperstein; O H Clark
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.